Other
Fovea
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT02322710Not ApplicableCompleted
Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds.
Role: collaborator
NCT01143818Completed
ESPRIT Study in Hypogonadal Men
Role: collaborator
NCT00697944Phase 4Unknown
Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients
Role: lead
All 3 trials loaded